Jimenez Krystal, Vargas Cristina, Garcia Karla, Guzman Herlinda, Angulo Marco, Billimek John
Health Policy Research Institute, University of California, Irvine (Ms Jimenez, Ms Vargas, Ms Garcia, Ms Guzman, Dr Billimek).
Department of Family Medicine, School of Medicine, University of California, Irvine (Dr Angulo, Dr Billimek).
Diabetes Educ. 2017 Feb;43(1):114-124. doi: 10.1177/0145721716675740. Epub 2016 Nov 10.
Purpose The purpose of this study was to examine the reliability and validity of a Spanish version of the Beliefs about Medicines Questionnaire (BMQ) as a measure to evaluate beliefs about medications and to differentiate adherent from nonadherent patients among low-income Latino patients with diabetes in the United States. Methods Seventy-three patients were administered the BMQ and surveyed for evidence of medication nonadherence. Internal consistency of the BMQ was assessed by Cronbach's alpha along with performing a confirmatory factor analysis. Criterion validity was assessed by comparing mean scores on 3 subscales of the BMQ (General Overuse, General Harm, and Specific Necessity-Concerns difference score) between adherent patients and patients reporting nonadherence for 3 different reasons (unintentional nonadherence, cost-related nonadherence, and nonadherence due to reasons other than cost) using independent samples t tests. Results The BMQ is a reliable instrument to examine beliefs about medications in this Spanish-speaking population. Construct validity testing shows nearly identical factor loading as the original construct map. General Overuse scores were significantly more negative for patients reporting each reason for nonadherence compared with their adherent counterparts. Necessity-Concerns difference scores were significantly more negative for patients reporting nonadherence for reasons other than cost compared with those who did not report this reason for nonadherence. Conclusion The Spanish version of the BMQ is appropriate to assess beliefs about medications in Latino patients with type 2 diabetes in the United States and may help identify patients who become nonadherent to medications for reasons other than out-of-pocket costs.
目的 本研究旨在检验西班牙语版《药物信念问卷》(BMQ)作为一种评估药物信念以及区分美国低收入拉丁裔糖尿病患者中依从性和非依从性患者的测量工具的信度和效度。方法 对73名患者进行BMQ测试,并调查其药物不依从的证据。通过Cronbach's α评估BMQ的内部一致性,并进行验证性因素分析。通过独立样本t检验比较依从性患者与因3种不同原因(无意不依从、费用相关不依从和非费用原因导致的不依从)报告不依从的患者在BMQ的3个分量表(总体过度使用、总体危害和特定必要性 - 担忧差异得分)上的平均得分,以评估效标效度。结果 BMQ是一种可靠的工具,可用于检验该西班牙语人群对药物的信念。结构效度测试显示,其因素负荷与原始结构模型几乎相同。与依从性患者相比,报告每种不依从原因的患者的总体过度使用得分显著更负。与未报告该不依从原因的患者相比,报告非费用原因导致不依从的患者的必要性 - 担忧差异得分显著更负。结论 西班牙语版BMQ适用于评估美国拉丁裔2型糖尿病患者对药物的信念,并可能有助于识别因自付费用以外的原因而不依从药物治疗的患者。